Furthermore, tumor infiltration of CD8+ T cells, which is a critical factor for type I IFN-elicited antitumor immunity, was reported to be lower in ER-positive BC than in other immunogenic tumor types [32]. The gene discussed is CD8A; the disease is breast cancer.